日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A syringeable immunotherapeutic hydrogel enhances T cell immunity via in-situ activation of STING pathway for advanced breast cancer postoperative therapy.

一种可注射的免疫治疗水凝胶通过原位激活 STING 通路来增强 T 细胞免疫力,用于晚期乳腺癌术后治疗

Zhang Baozhen, Li Min, Ji Jiahua, Si Xinghui, Yin Xiaojiao, Ji Guofeng, Ren Liqun, Yao Haochen

Erratum: CircZCCHC2 decreases pirarubicin sensitivity and promotes triple-negative breast cancer development via the miR-1200/TPR axis

更正:CircZCCHC2通过miR-1200/TPR轴降低吡柔比星敏感性并促进三阴性乳腺癌的发生发展。

Zhang, Fan; Wei, Dexian; Xie, Shishun; Ren, Liqun; Qiao, Sennan; Li, Liying; Ji, Jiahua; Fan, Zhimin